Skip to main navigation Skip to search Skip to main content

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

  • Cell Therapy Consortium

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry